SIHUAN PHARMACE
Research SIHUAN PHARMACE (TEL1) on Bullrun: market cap EUR 825.49M, dividend yield 2.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTEL1
- ExchangeF
- CountryHong Kong
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 825.49M
- Dividend yield2.8%
- Financial periodFY2025
- RevenueCNY 2.62B
- Revenue growth37.7%
- Net incomeCNY 179.70M
- Free cash flow-CNY 218.06M
- Gross margin68.8%
Valuation Snapshot
latest market cap is EUR 825.49M; dividend yield is 2.8%.
Peer valuation comparison
Latest dividend yield is 2.84% versus a Healthcare sector median of 2.11% (34.6% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 2.62B | CNY 179.70M | -CNY 218.06M | 68.8% | 0.02 | CNY 3.56B | CNY 1.01B | CNY 5.85B |
| FY2024 | CNY 1.90B | -CNY 216.66M | CNY 89.77M | 65.3% | -0.02 | CNY 3.52B | CNY 974.01M | CNY 4.37B |
| FY2023 | CNY 1.86B | -CNY 54.02M | -CNY 95.93M | 69.6% | -0.01 | CNY 3.78B | CNY 1.26B | CNY 4.43B |
| FY2022 | CNY 2.18B | -CNY 1.91B | -CNY 547.44M | 68.2% | -0.21 | CNY 4.01B | CNY 1.29B | CNY 4.74B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | EUR 825.49M | n/a | 2.6% | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR, yield 2.8%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0 CNY |
| FY2024 | 0 CNY |
| FY2023 | 0 CNY |
| FY2022 | 0.02 CNY |
| FY2021 | 0 CNY |
About SIHUAN PHARMACE
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China, the United States, and internationally. It operates in three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is SIHUAN PHARMACE's market cap?
SIHUAN PHARMACE's market capitalization is EUR 825.49M.
Does SIHUAN PHARMACE pay a dividend?
SIHUAN PHARMACE has a dividend yield of 2.8%.
What does SIHUAN PHARMACE do?
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China, the United States, and internationally. It operates in three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The company offers filling, shaping, supporting, supplementing, optoelectronic devices, body sculpturing, skin care, and other services, as well as non- or minimally invasive comprehensive medical aesthetics solutions.